How genedrive brought its investor communications in-house to gain clarity on who is making the most noise.
Taking control of the investor narrative: with an investor base ranging from committed long-term shareholders to more transient retail participants, genedrive needed to understand exactly who it was talking to. InvestorHub gave it the platform to bring communications fully in-house and the data to tell the difference.
- Industry
- Point-of-care pharmacogenetic diagnostics
Problem
genedrive plc is an AIM-quoted pharmacogenetic testing company whose diagnostic kits — the MT-RNR1 ID Kit and the CYP2C19 ID Kit — are designed to support treatment decisions at the point of care. Before InvestorHub there were too many intermediaries between the company and its investors, and limited visibility into whether communications were landing, who was reading them, or what questions they were generating.
Solution
The Hub gives genedrive direct ownership of the investor relationship and control of the full investor journey — from the first time someone lands on the Hub through to how they engage with announcements and updates. Formal market announcements are published alongside more accessible supporting content that explains the broader context and significance of company developments, all from one place.
Impact
genedrive now owns the investor relationship end to end, with a single location for company updates and a direct route to shareholders. Milestones such as FDA Breakthrough Device Designation, NHS Scotland rollout activity and new clinical research are published with plain-English explanations alongside the formal announcement, and the team can see which investors are engaging — telling committed long-term shareholders apart from more transient retail participants.
We now control the full investor journey — from the first time someone lands on the Hub, through to how they engage with our announcements and updates.
How they did it
- 1
What was the case for bringing investor communications in-house, and how did InvestorHub make that possible?
Before, there were too many intermediaries between us and our investors and we had limited visibility into whether they were landing, who was reading them, or what questions were being generated. The Hub has given us direct ownership of that relationship. We now control the full investor journey — from the first time someone lands on the Hub, through to how they engage with our announcements and updates. That's a much healthier position for a company at our stage, where the ability to clearly communicate our commercial progress really matters.
- 2
How has the platform supported your communications approach?
One of the things we have valued most is the simplicity of the platform. It allows us to publish formal market announcements alongside more accessible supporting content that helps explain the broader context and significance of company developments. For example, when announcing milestones such as FDA Breakthrough Device Designation, NHS Scotland rollout activity, or new clinical research, we can provide additional plain-English explanations to help investors better understand the clinical and commercial relevance. Having everything in one place also makes it easier internally to manage communications efficiently and maintain consistency across updates.
- 3
What have you found most useful so far?
The platform has been easy to use and has helped us streamline our investor communications process. It has also provided a more direct route for sharing information with shareholders and ensuring company updates are accessible in a single location. The experience so far has been positive in terms of usability, accessibility, and helping us centralise investor communications more effectively.
Features used
Explore more case studies
ValiRx (AIM:VAL)
How ValiRx uses InvestorHub to communicate a complex pipeline to a specialist investor base.
Building trust through transparency in clinical-stage biotech: ValiRx's retail shareholders, specialist biotech investors and healthcare-focused funds expect regular, substantive updates — and the hub has become the company's primary channel for delivering them at scale.
Read the case studyAdsure Services (AQSE:ADS)
How Adsure Services built a professional investor presence from the ground up.
How Adsure Services CEO Kevin Limn increased retail shareholder engagement by taking control of the company's investor journey with InvestorHub.
Read the case studyArtisanal Spirits Company (AIM:ART)
How the Artisanal Spirits Company turned its members into shareholders.
ART rebuilt its investor website as an interactive hub, then used shareholder identification and an enhanced benefits programme to convert loyal customers into investors.
Read the case studyTake control of your register
See how InvestorHub helps listed companies close the distance to their shareholders.